JP2015522608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522608A5 JP2015522608A5 JP2015523049A JP2015523049A JP2015522608A5 JP 2015522608 A5 JP2015522608 A5 JP 2015522608A5 JP 2015523049 A JP2015523049 A JP 2015523049A JP 2015523049 A JP2015523049 A JP 2015523049A JP 2015522608 A5 JP2015522608 A5 JP 2015522608A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- penetamate
- caking agent
- pnt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 27
- 238000000034 method Methods 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 5
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical group OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims 3
- 239000003755 preservative agent Substances 0.000 claims 3
- 230000002335 preservative effect Effects 0.000 claims 3
- 239000004094 surface-active agent Substances 0.000 claims 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 2
- 239000002270 dispersing agent Substances 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 239000000787 lecithin Substances 0.000 claims 2
- 235000010445 lecithin Nutrition 0.000 claims 2
- 229940067606 lecithin Drugs 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 2
- 238000010254 subcutaneous injection Methods 0.000 claims 2
- 239000007929 subcutaneous injection Substances 0.000 claims 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 1
- 235000019445 benzyl alcohol Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000001087 glyceryl triacetate Substances 0.000 claims 1
- 235000013773 glyceryl triacetate Nutrition 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000004396 mastitis Diseases 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000008719 thickening Effects 0.000 claims 1
- 229960002622 triacetin Drugs 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ60129912 | 2012-07-17 | ||
| NZ601299 | 2012-07-17 | ||
| NZ61017513 | 2013-05-03 | ||
| NZ610175 | 2013-05-03 | ||
| NZ613138A NZ613138B2 (en) | 2013-07-12 | Injectable antibiotic formulations and their methods of use | |
| NZ613138 | 2013-07-12 | ||
| PCT/NZ2013/000123 WO2014014363A1 (en) | 2012-07-17 | 2013-07-16 | Injectable antibiotic formulations and their methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015522608A JP2015522608A (ja) | 2015-08-06 |
| JP2015522608A5 true JP2015522608A5 (cg-RX-API-DMAC10.html) | 2016-09-01 |
| JP6189437B2 JP6189437B2 (ja) | 2017-08-30 |
Family
ID=49949085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523049A Active JP6189437B2 (ja) | 2012-07-17 | 2013-07-16 | 注射用抗生物質製剤およびその使用方法 |
Country Status (30)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2729328T3 (es) * | 2012-12-20 | 2019-10-31 | Alleva Animal Health Ltd | Formulaciones inyectables veterinarias de penetamato |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE49768B1 (en) | 1979-05-21 | 1985-12-11 | Leo Pharm Prod Ltd | 6beta-halopenicillanic acid derivatives |
| IE51516B1 (en) * | 1980-10-06 | 1987-01-07 | Leo Pharm Prod Ltd | 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate |
| IL64009A (en) | 1980-10-31 | 1984-09-30 | Rech Applications Therap | Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them |
| IE51846B1 (en) | 1980-11-17 | 1987-04-15 | Leo Pharm Prod Ltd | Pharmaceutical preparation for veterinary use and an appliance containing it |
| EP0115001B1 (de) | 1982-12-28 | 1988-06-15 | Bayer Ag | Stabile Aminoglykosid-Penicillin-Injektionsformulierungen |
| US5736151A (en) | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
| CH693625A5 (it) * | 1999-02-18 | 2003-11-28 | Inpharma Sa | Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi. |
| US20040022815A1 (en) | 2002-08-05 | 2004-02-05 | Orchid Health Care | Novel pharmaceutical composition of ceftiofur |
| KR20040015622A (ko) | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물 |
| US6911441B2 (en) | 2002-12-16 | 2005-06-28 | Akzo Nobel N.V. | Prolonged release pharmaceutical composition |
| CN1517090A (zh) | 2003-01-20 | 2004-08-04 | 王玉万 | 含抗菌药物的兽用混悬注射剂或乳剂 |
| US20050143347A1 (en) * | 2003-12-22 | 2005-06-30 | Aventis Pharma Deutschland Gmbh | Medicinal lipolysis of accumulations of fat |
| DE102004025324A1 (de) * | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
| US20060142234A1 (en) | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
| US8679540B2 (en) * | 2006-06-09 | 2014-03-25 | Flamel Technologies | Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| PL2214656T3 (pl) * | 2007-10-26 | 2019-06-28 | Avivagen Inc. | Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej |
| HRP20140939T1 (hr) * | 2008-05-07 | 2014-11-21 | Salix Pharmaceuticals, Ltd. | Davanje preparata za äśišä†enje crijeva i antibiotika za lijeäśenje bolesti crijeva |
| US8501800B2 (en) | 2009-03-05 | 2013-08-06 | Insite Vision Incorporated | Controlled-release ophthalmic vehicles |
| WO2010138918A1 (en) * | 2009-05-29 | 2010-12-02 | Pacira Pharmaceuticals, Inc. | Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent |
| CN101822637A (zh) | 2009-12-31 | 2010-09-08 | 天津瑞普生物技术股份有限公司 | 一种含有β-内酰胺类抗生素的混悬注射剂 |
| US20110223208A1 (en) * | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| DE102010015143A1 (de) | 2010-04-16 | 2011-10-20 | Cts Chemical Industries Ltd. | Stabile flüssige ölige gebrauchsfertige Formulierungen, Herstellung davon und Verwendung davon |
| EP2723335A4 (en) * | 2011-06-23 | 2015-01-07 | Bayer New Zealand Ltd | ANTIPARASITIC COMPOSITION WITH A MACROCYCLIC LACTON AND LEVAMISOL AND METHOD FOR THE TREATMENT OF PARASITIC ATTACK |
| AU2012359296B2 (en) | 2011-12-23 | 2014-12-11 | Elanco New Zealand | Antibiotic formulations |
| WO2013129944A1 (en) * | 2012-02-27 | 2013-09-06 | Bayer New Zealand Limited | Controlled release compositions and their methods of use |
-
2013
- 2013-07-16 PL PL13819728T patent/PL2874624T3/pl unknown
- 2013-07-16 AU AU2013290826A patent/AU2013290826B2/en active Active
- 2013-07-16 HU HUE13819728A patent/HUE046427T2/hu unknown
- 2013-07-16 KR KR1020157001143A patent/KR102113822B1/ko active Active
- 2013-07-16 WO PCT/NZ2013/000123 patent/WO2014014363A1/en not_active Ceased
- 2013-07-16 MX MX2018009121A patent/MX387668B/es unknown
- 2013-07-16 EP EP13819728.0A patent/EP2874624B8/en active Active
- 2013-07-16 ES ES13819728T patent/ES2752034T3/es active Active
- 2013-07-16 LT LT13819728T patent/LT2874624T/lt unknown
- 2013-07-16 RU RU2015105251A patent/RU2643327C2/ru active
- 2013-07-16 JP JP2015523049A patent/JP6189437B2/ja active Active
- 2013-07-16 MX MX2014015927A patent/MX358248B/es active IP Right Grant
- 2013-07-16 MY MYPI2014703596A patent/MY172561A/en unknown
- 2013-07-16 DK DK13819728T patent/DK2874624T3/da active
- 2013-07-16 CN CN201380038000.4A patent/CN104470517B/zh active Active
- 2013-07-16 PT PT138197280T patent/PT2874624T/pt unknown
- 2013-07-16 SI SI201331584T patent/SI2874624T1/sl unknown
- 2013-07-16 HR HRP20191730 patent/HRP20191730T1/hr unknown
- 2013-07-16 UA UAA201501302A patent/UA118654C2/uk unknown
- 2013-07-16 BR BR112014031083-1A patent/BR112014031083B1/pt active IP Right Grant
- 2013-07-16 CA CA2875351A patent/CA2875351C/en active Active
- 2013-07-16 US US14/415,940 patent/US10376585B2/en active Active
-
2014
- 2014-12-02 CR CR20140550A patent/CR20140550A/es unknown
- 2014-12-04 PH PH12014502716A patent/PH12014502716B1/en unknown
- 2014-12-17 CL CL2014003423A patent/CL2014003423A1/es unknown
- 2014-12-18 DO DO2014000288A patent/DOP2014000288A/es unknown
- 2014-12-18 ZA ZA2014/09322A patent/ZA201409322B/en unknown
- 2014-12-19 NI NI201400152A patent/NI201400152A/es unknown
- 2014-12-22 SV SV2014004882A patent/SV2014004882A/es unknown
- 2014-12-26 CO CO14284224A patent/CO7240359A2/es unknown
-
2015
- 2015-01-14 IL IL236713A patent/IL236713B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017001115A1 (es) | Formulación estable de proteina en solución que contiene una alta concentración de un anticuerpo anti-vegf. | |
| NZ745859A (en) | Antiparasitic isoxazoline compounds, long-acting injectable formulations comprising them, methods and uses thereof | |
| EA201991299A1 (ru) | Приготовление твердых циклодекстриновых комплексов для доставки офтальмологических активных фармацевтических ингредиентов | |
| CL2018003178A1 (es) | Composición farmacéutica | |
| MX361716B (es) | Formulaciones peptidicas de liberacion controlada. | |
| HK1204770A1 (en) | Compartmentalized method of nucleic acid delivery and compositions and uses thereof | |
| FI2887923T3 (fi) | Polyoksylilipidin tai polyoksylirasvahapon oftalminen formulaatio ja silmätilojen hoito | |
| ECSP21043639A (es) | Formulación de solución de proteínas que contiene una alta concentración de un anticuerpo anti-vegf | |
| JP2017519568A5 (cg-RX-API-DMAC10.html) | ||
| WO2016100949A3 (en) | Method and compositions for dissolving or solubilizing therapeutic agents | |
| RU2016129193A (ru) | Составы на основе берберина и их применение | |
| FI3373976T3 (fi) | Topikaalisia formulaatioita ja niiden käyttöjä | |
| RU2015105251A (ru) | Инъецируемые составы антибиотиков и способы их применения | |
| RU2016135034A (ru) | Стабильный спиртовой раствор алпростадила | |
| AR094882A1 (es) | Selamectina para el tratamiento de las infestaciones por piojos de mar, composición | |
| AR130115A2 (es) | Formulación de solución de proteína estable que contiene alta concentración de un anticuerpo anti-vegf | |
| AR102572A1 (es) | Formulación de solución de proteína estable que contiene alta concentración de un anticuerpo anti-vegf | |
| RU2011122741A (ru) | Фармацевтическая композиция для лечения заболеваний кожи и способ ее получения | |
| JP2014156481A (ja) | 核酸を有効成分とする外用剤組成物 | |
| JPWO2013154045A1 (ja) | 注射剤用組成物 | |
| CN106604723A8 (zh) | 更易于超声经皮传递的药物制剂的改良 | |
| TH167877A (th) | สูตรผสมใหม่สำหรับโกนาโดโทรพิน | |
| BR112016027149A8 (pt) | sistema terapêutico transdérmico para a administração transdérmica de rotigotina, uso do referido sistema, método de fabricação do sistema e uso de uma mistura de polímeros de polivinilpirrolidona | |
| TW201838624A (zh) | 用於經皮遞送藥物的醫藥載體及含其的醫藥組合物 | |
| NZ767204A (en) | Aripiprazole prodrug compositions |